Alpha Tau Medical (DRTS) Competitors $2.57 +0.04 (+1.58%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.56 -0.01 (-0.54%) As of 04/17/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DRTS vs. AXGN, EMBC, IRMD, BVS, BFLY, RXST, AVNS, SIBN, CBLL, and KIDSShould you be buying Alpha Tau Medical stock or one of its competitors? The main competitors of Alpha Tau Medical include AxoGen (AXGN), Embecta (EMBC), Iradimed (IRMD), Bioventus (BVS), Butterfly Network (BFLY), RxSight (RXST), Avanos Medical (AVNS), SI-BONE (SIBN), CeriBell (CBLL), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry. Alpha Tau Medical vs. AxoGen Embecta Iradimed Bioventus Butterfly Network RxSight Avanos Medical SI-BONE CeriBell OrthoPediatrics Alpha Tau Medical (NASDAQ:DRTS) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk, community ranking and dividends. Do institutionals & insiders believe in DRTS or AXGN? 2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by insiders. Comparatively, 7.0% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has preferable earnings and valuation, DRTS or AXGN? AxoGen has higher revenue and earnings than Alpha Tau Medical. AxoGen is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Tau MedicalN/AN/A-$29.16M-$0.45-5.71AxoGen$187.34M3.69-$21.72M-$0.22-70.77 Do analysts rate DRTS or AXGN? Alpha Tau Medical presently has a consensus target price of $8.00, indicating a potential upside of 211.28%. AxoGen has a consensus target price of $22.60, indicating a potential upside of 45.15%. Given Alpha Tau Medical's higher probable upside, research analysts plainly believe Alpha Tau Medical is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00AxoGen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is DRTS or AXGN more profitable? Alpha Tau Medical has a net margin of 0.00% compared to AxoGen's net margin of -7.91%. AxoGen's return on equity of -14.91% beat Alpha Tau Medical's return on equity.Company Net Margins Return on Equity Return on Assets Alpha Tau MedicalN/A -38.62% -29.89% AxoGen -7.91%-14.91%-7.49% Which has more risk & volatility, DRTS or AXGN? Alpha Tau Medical has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, AxoGen has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500. Does the MarketBeat Community prefer DRTS or AXGN? AxoGen received 437 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 72.89% of users gave AxoGen an outperform vote while only 71.43% of users gave Alpha Tau Medical an outperform vote. CompanyUnderperformOutperformAlpha Tau MedicalOutperform Votes2071.43% Underperform Votes828.57% AxoGenOutperform Votes45772.89% Underperform Votes17027.11% Does the media prefer DRTS or AXGN? In the previous week, AxoGen had 7 more articles in the media than Alpha Tau Medical. MarketBeat recorded 8 mentions for AxoGen and 1 mentions for Alpha Tau Medical. AxoGen's average media sentiment score of 1.13 beat Alpha Tau Medical's score of 1.00 indicating that AxoGen is being referred to more favorably in the news media. Company Overall Sentiment Alpha Tau Medical Positive AxoGen Positive SummaryAxoGen beats Alpha Tau Medical on 12 of the 16 factors compared between the two stocks. Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DRTS vs. The Competition Export to ExcelMetricAlpha Tau MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$180.88M$4.04B$5.30B$7.35BDividend YieldN/A39.51%5.12%4.30%P/E Ratio-5.9827.6821.8017.80Price / SalesN/A47.06379.9697.74Price / CashN/A51.0838.2634.64Price / Book2.125.816.443.98Net Income-$29.16M$67.09M$3.21B$247.73M7 Day Performance0.78%1.97%2.87%1.81%1 Month Performance-1.91%-4.84%-8.63%-6.98%1 Year Performance-3.38%14.47%11.46%1.37% Alpha Tau Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DRTSAlpha Tau Medical2.6535 of 5 stars$2.57+1.6%$8.00+211.3%-4.5%$180.88MN/A-5.9880Short Interest ↓News CoverageGap DownAXGNAxoGen2.9717 of 5 stars$16.06+1.1%$22.60+40.7%+124.4%$712.17M$187.34M-50.19450Short Interest ↑Positive NewsEMBCEmbecta4.5127 of 5 stars$11.90-3.3%$20.33+70.9%+10.7%$691.80M$1.11B11.901,900Gap DownIRMDIradimed4.8749 of 5 stars$53.03+1.4%$72.00+35.8%+27.9%$674.28M$73.24M35.35110Short Interest ↓Positive NewsBVSBioventus3.2028 of 5 stars$7.92+5.9%$15.00+89.4%+66.4%$612.94M$573.28M-12.981,200News CoveragePositive NewsGap DownBFLYButterfly Network2.4745 of 5 stars$2.53+2.8%$3.00+18.6%+185.0%$597.59M$82.06M-5.50460News CoverageGap DownRXSTRxSight3.0282 of 5 stars$14.42+2.4%$39.78+175.9%-72.7%$583.88M$139.93M-17.37220Analyst ForecastNews CoverageGap UpAVNSAvanos Medical3.2228 of 5 stars$12.42-0.4%N/A-33.7%$571.36M$687.80M36.534,040SIBNSI-BONE4.1647 of 5 stars$13.36-0.1%$24.40+82.6%-9.1%$567.17M$167.18M-14.52350Positive NewsGap DownCBLLCeriBellN/A$14.88-0.8%$32.50+118.4%N/A$533.72M$65.44M0.00N/AGap UpKIDSOrthoPediatrics4.3193 of 5 stars$20.98-0.9%$37.00+76.4%-29.8%$509.54M$204.73M-17.06200 Related Companies and Tools Related Companies AXGN Alternatives EMBC Alternatives IRMD Alternatives BVS Alternatives BFLY Alternatives RXST Alternatives AVNS Alternatives SIBN Alternatives CBLL Alternatives KIDS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DRTS) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.